Steve Cohen: portfolio of Point72 Asset Management
Steve Cohen leads Point72, the successor to SAC Capital; the portfolio holds a very large number of positions and changes often.
Source: 13F filing with the US Securities and Exchange Commission dated Nov 14, 2024. It shows positions at quarter end and is filed up to 45 days later – today the positions may be several months old. It covers only securities traded on US exchanges, without short positions; securities traded only abroad and cash are not included. Form 13F filingInvestment managers with discretion over at least 100 million USD in reportable US securities (mainly stocks and ETFs, plus options and convertible bonds) report their holdings to the SEC within 45 days after each quarter. Short positions, securities traded only abroad and cash are not included.Example: Positions as of 30 Sep, filed on 14 Nov → they are already six weeks old when published.More in the Academy: Glossary
You are looking at Q3 2024. Go to the latest filing (Q3 2026)
- Total value of stock positions
- 28.1B USD
- Positions
- 1,136
- Share of the ten largest
- 10.4%
The ten largest positions Q3 2024
- Nvidia 1.6%▲ +74.5%
- Shell PLC 1.3%▲ +194.4%
- Arista Networks 1.2%▲ +31.8%
- Comcast 1.1%▲ +31.4%
- Macom Tech Solutions HLDGS I 1.0%▲ +173.9%
- Boston Scientific 1.0%▲ +8.2%
- Lumentum 0.9%▲ +23.6%
- Intuitive Surgical 0.8%▼ −23.5%
- Taiwan Semiconductor Manufacturing (ADR) 0.7%▲ +95.3%
- Coherent Corp. 0.7%▼ −43.9%
Show all positions of this quarter
Choose a quarter (50 filings)
- Q3 2026
- Q2 2026
- Q1 2026
- Q4 2025
- Q3 2025
- Q2 2025
- Q1 2025
- Q4 2024
- Q3 2024
- Q2 2024
- Q1 2024
- Q4 2023
- Q3 2023
- Q2 2023
- Q1 2023
- Q4 2022
- Q3 2022
- Q2 2022
- Q1 2022
- Q4 2021
- Q3 2021
- Q2 2021
- Q1 2021
- Q4 2020
- Q3 2020
- Q2 2020
- Q1 2020
- Q4 2019
- Q3 2019
- Q2 2019
- Q1 2019
- Q4 2018
- Q3 2018
- Q2 2018
- Q1 2018
- Q4 2017
- Q3 2017
- Q2 2017
- Q1 2017
- Q4 2016
- Q3 2016
- Q2 2016
- Q1 2016
- Q4 2015
- Q3 2015
- Q2 2015
- Q1 2015
- Q4 2014
- Q3 2014
- Q2 2014
All positions Q3 2024
| Symbol | Weight | Shares | Reported value | Change | Held since |
|---|---|---|---|---|---|
| CME CME Group | < 0.1% | 98,175 | 21.7M USD | −54.5% reduced | Q2 2014 or earlier 42 quarters |
| Xenon Pharmaceuticals Inc | < 0.1% | 383,290 | 15.1M USD | −20.5% reduced | Q1 2015 39 quarters |
| Select Sector SPDR TR | < 0.1% | 289,218 | 13.1M USD | +143.9% increased | Q4 2016 32 quarters |
| Alaska Air Group Inc | 0.1% | 911,944 | 41.2M USD | −69.3% reduced | Q2 2018 26 quarters |
| Bread Financial Holdings Inc | < 0.1% | 71,035 | 3.4M USD | −89.0% reduced | Q4 2018 24 quarters |
| FIS Fidelity National Information Services | 0.1% | 374,053 | 31.3M USD | +1,112.9% increased | Q1 2019 23 quarters |
| Select Sector SPDR TR | < 0.1% | 10,000 | 878.0K USD | −86.9% reduced | Q1 2019 23 quarters |
| Performance Food Group Co | 0.4% | 1,612,688 | 126.4M USD | −5.7% reduced | Q2 2019 22 quarters |
| DD DuPont | < 0.1% | 284,437 | 25.3M USD | −77.6% reduced | Q2 2019 22 quarters |
| TRGP Targa Resources | 0.1% | 223,041 | 33.0M USD | +87.5% increased | Q3 2019 21 quarters |
| Bicycle Therapeutics PLC | < 0.1% | 899,799 | 20.4M USD | +1,438.1% increased | Q4 2019 20 quarters |
| GM General Motors | < 0.1% | 599,830 | 26.9M USD | −78.1% reduced | Q2 2020 18 quarters |
| Uniqure NV | < 0.1% | 976,893 | 4.8M USD | +336.1% increased | Q2 2020 18 quarters |
| CSX CSX Corporation | 0.3% | 2,793,090 | 96.4M USD | −51.3% reduced | Q3 2020 17 quarters |
| MAT Mattel | 0.1% | 1,582,369 | 30.1M USD | +54.5% increased | Q3 2020 17 quarters |
| Transalta Corp | < 0.1% | 1,286,800 | 13.3M USD | +37.8% increased | Q3 2020 17 quarters |
| Post HLDGS Inc | 0.3% | 681,300 | 78.9M USD | −44.9% reduced | Q4 2020 16 quarters |
| Inspire Med Sys Inc | 0.2% | 319,364 | 67.4M USD | +954.4% increased | Q4 2020 16 quarters |
| RUN Sunrun | 0.2% | 2,343,681 | 42.3M USD | −21.5% reduced | Q4 2020 16 quarters |
| Ultragenyx Pharmaceutical In | 0.1% | 653,660 | 36.3M USD | +21.1% increased | Q4 2020 16 quarters |
| CCEP Coca-Cola Europacific Partners | < 0.1% | 169,457 | 13.3M USD | −85.9% reduced | Q4 2020 16 quarters |
| Alphatec HLDGS Inc | < 0.1% | 860,096 | 4.8M USD | −73.1% reduced | Q4 2020 16 quarters |
| ANET Arista Networks | 1.2% | 878,122 | 337.0M USD | +31.8% increased | Q1 2021 15 quarters |
| VST Vistra Corp. | 0.2% | 593,306 | 70.3M USD | −61.4% reduced | Q1 2021 15 quarters |
| VMC Vulcan Materials Company | < 0.1% | 105,891 | 26.5M USD | −49.8% reduced | Q1 2021 15 quarters |
| Olin Corp | < 0.1% | 380,607 | 18.3M USD | +13.1% increased | Q1 2021 15 quarters |
| Green Plains Inc | < 0.1% | 556,095 | 7.5M USD | +29.5% increased | Q1 2021 15 quarters |
| Dyne Therapeutics Inc | < 0.1% | 102,480 | 3.7M USD | −71.3% reduced | Q1 2021 15 quarters |
| RCL Royal Caribbean Group | < 0.1% | 10,268 | 1.8M USD | −99.1% reduced | Q1 2021 15 quarters |
| BP BP (ADR) | 0.3% | 2,763,816 | 86.8M USD | −29.4% reduced | Q2 2021 14 quarters |
| Centessa Pharmaceuticals PLC | 0.2% | 2,715,663 | 43.4M USD | +54.1% increased | Q2 2021 14 quarters |
| Triumph Group Inc New | < 0.1% | 1,112,112 | 14.3M USD | −26.7% reduced | Q2 2021 14 quarters |
| Teck Resources Ltd | < 0.1% | 140,793 | 7.4M USD | −68.5% reduced | Q2 2021 14 quarters |
| BSX Boston Scientific | 1.0% | 3,381,819 | 283.4M USD | +8.2% increased | Q3 2021 13 quarters |
| Bath & Body Works Inc | 0.6% | 5,015,220 | 160.1M USD | +41.7% increased | Q3 2021 13 quarters |
| Ambarella Inc | 0.2% | 862,084 | 48.6M USD | +70.0% increased | Q3 2021 13 quarters |
| Acv Auctions Inc | < 0.1% | 652,949 | 13.3M USD | +17.4% increased | Q3 2021 13 quarters |
| TTWO Take-Two Interactive | < 0.1% | 16,255 | 2.5M USD | −98.0% reduced | Q3 2021 13 quarters |
| Vincerx Pharma Inc | < 0.1% | 674,193 | 482.7K USD | unchanged | Q3 2021 13 quarters |
| Omega Therapeutics Inc | < 0.1% | 116,009 | 141.5K USD | unchanged | Q3 2021 13 quarters |
| Stoneco Ltd | 0.5% | 11,422,475 | 128.6M USD | +36.2% increased | Q4 2021 12 quarters |
| PCG PG&E Corporation | 0.4% | 5,107,986 | 101.0M USD | +2.7% increased | Q4 2021 12 quarters |
| FIVE9 Inc | < 0.1% | 699,104 | 20.1M USD | −7.2% reduced | Q4 2021 12 quarters |
| Tpi Composites Inc | < 0.1% | 931,606 | 4.2M USD | −46.1% reduced | Q4 2021 12 quarters |
| Equity Residential | < 0.1% | 56,191 | 4.2M USD | −42.7% reduced | Q4 2021 12 quarters |
| BABA Alibaba Group (ADR) | < 0.1% | 28,810 | 3.1M USD | −97.7% reduced | Q4 2021 12 quarters |
| Anaptysbio Inc | < 0.1% | 54,200 | 1.8M USD | +202.8% increased | Q4 2021 12 quarters |
| Hertz Global HLDGS Inc | < 0.1% | 321,027 | 1.1M USD | unchanged | Q4 2021 12 quarters |
| X4 Pharmaceuticals Inc | < 0.1% | 625,052 | 418.3K USD | +15.1% increased | Q4 2021 12 quarters |
| Bellring Brands Inc | 0.6% | 2,588,970 | 157.2M USD | +21.5% increased | Q1 2022 11 quarters |
“Held since”: the first quarter from which the position appears in the 13F filing at every quarter end. It first appears at the end of that quarter – the filing gives neither date nor price, and trading between two quarter ends is not visible. “Or earlier”: the position was already in the first available filing (or the first one after a gap in filings). After a change of the security identifier (e.g. a renaming) the start may appear later.
Show more (up to 500) Shown: the 50 longest-held of 1,136 positions.
Plus 753 option positions, value of the underlying shares as reported 10.6B USD – not included in the weights.
The filing states the value of the shares the options refer to. Whether a put is a hedge or a bet on falling prices is not stated in the filing.
- SPDR S&P 500 ETF TR Put 2.4B USD
- Invesco QQQ TR Put 1.7B USD
- SPDR S&P 500 ETF TR Call 1.2B USD
- Ishares TR Put 344.6M USD
- Select Sector SPDR TR Put 107.1M USD
- Apple Inc. Call 106.6M USD
- Select Sector SPDR TR Put 88.0M USD
- Boeing Call 77.9M USD
- SPDR Ser TR Put 59.3M USD
- Select Sector SPDR TR Put 58.9M USD
Plus 42 positions in convertible bonds and bonds worth 573.6M USD as reported – not included in the weights.
Convertible bonds and bonds, principal amount as reported. They are not stock positions and therefore do not count towards the weights.
- Sea Ltd principal 35.0M USD 42.0M USD
- Cytokinetics Inc principal 29.7M USD 38.4M USD
- Bridgebio Pharma Inc principal 32.5M USD 33.5M USD
- Mirum Pharmaceuticals Inc principal 18.9M USD 27.9M USD
- Lci Inds principal 25.0M USD 25.5M USD
- Zscaler Inc principal 20.0M USD 24.5M USD
- Cheesecake Factory Inc principal 25.8M USD 24.4M USD
- Lumentum HLDGS Inc principal 20.5M USD 23.7M USD
- Snap Inc principal 27.3M USD 23.4M USD
- Ncl Corp Ltd principal 18.8M USD 23.4M USD
Breakdown by sector
- Technology 10.7%
- Industrials 6.1%
- Health Care 6.0%
- Financials 5.0%
- Utilities 3.8%
- Communication Services 3.0%
- Energy 3.0%
- Consumer Discretionary 2.7%
- Consumer Staples 2.4%
- Materials 1.7%
- Real Estate 1.2%
- not in our coverage 54.2%
Sectors only for stocks we cover; the rest is grouped under “not in our coverage”.
How to read this page
- Weight: a position’s share of the total value of all reported stock positions in this quarter – options and bonds are not counted.
- Change: number of shares compared with the previous quarter. After a stock split we convert the previous quarter’s share count so that a split does not look like an increase; if a possible split cannot be confirmed, “–” is shown.
- Reported value: value of the position at quarter end as reported by the investor. The portfolio may have changed since then.
All superinvestor portfolios Screener: stocks held by superinvestors